CN Stock MarketDetailed Quotes

300294 China Resources Boya Bio-pharmaceutical Group

Watchlist
  • 32.34
  • +0.64+2.02%
Market Closed Nov 7 15:00 CST
16.31BMarket Cap87.64P/E (TTM)

China Resources Boya Bio-pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-43.16%1.25B
-41.87%895.74M
-44.36%448.45M
-3.87%2.65B
5.17%2.19B
10.16%1.54B
23.11%805.93M
4.08%2.76B
3.54%2.08B
8.02%1.4B
Operating revenue
-43.16%1.25B
-41.87%895.74M
-44.36%448.45M
-3.87%2.65B
5.17%2.19B
10.16%1.54B
23.11%805.93M
4.08%2.76B
3.54%2.08B
8.02%1.4B
Other operating revenue
----
-7.47%576.89K
----
138.05%845.92K
----
120.05%623.44K
----
-142.70%-2.22M
----
-151.32%-3.11M
Total operating cost
-51.21%853.44M
-51.85%590.06M
-52.53%301.27M
-6.07%2.09B
6.17%1.75B
12.15%1.23B
22.64%634.66M
2.41%2.22B
1.18%1.65B
2.91%1.09B
Operating cost
-62.07%415.05M
-61.74%295.36M
-65.93%144.46M
0.16%1.25B
16.92%1.09B
21.69%772.07M
42.64%424.06M
9.71%1.25B
7.84%935.94M
12.04%634.46M
Operating tax surcharges
-17.43%12.96M
-25.25%8.02M
-29.07%4.02M
-8.43%20.07M
-6.11%15.7M
3.03%10.73M
16.30%5.66M
9.67%21.92M
22.02%16.72M
16.50%10.41M
Operating expense
-39.71%273.79M
-39.81%192.73M
-34.36%104.04M
-16.23%582.59M
-12.33%454.12M
-5.47%320.21M
-4.73%158.5M
-9.43%695.45M
-6.81%517.97M
-6.20%338.73M
Administration expense
-20.14%127.76M
-20.14%80.67M
-15.06%37.96M
-15.27%194.85M
0.26%159.98M
2.39%101.01M
-7.47%44.69M
12.96%229.97M
13.05%159.57M
19.06%98.66M
Financial expense
-1.65%-23.49M
-4.35%-17.04M
0.34%-8.21M
-20.63%-30.49M
-26.14%-23.11M
-32.30%-16.33M
-32.77%-8.23M
-22.68%-25.28M
-606.60%-18.32M
-600.57%-12.35M
-Interest expense (Financial expense)
-69.64%125.07K
-62.90%104.47K
-83.78%18.61K
-26.86%455.59K
-19.97%412K
-20.23%281.61K
-35.65%114.73K
-94.08%622.91K
-93.21%514.8K
-92.43%353.01K
-Interest Income (Financial expense)
-0.26%-23.87M
-3.36%-17.32M
1.78%-8.27M
-19.44%-31.29M
-24.77%-23.81M
-30.01%-16.75M
-30.42%-8.42M
16.83%-26.2M
-82.00%-19.08M
-94.32%-12.89M
Research and development
-1.38%47.38M
-19.58%30.32M
90.36%19.01M
36.54%67.7M
34.85%48.04M
65.56%37.71M
45.32%9.98M
-16.38%49.58M
-31.85%35.63M
-48.68%22.77M
Credit Impairment Loss
-303.88%-2.91M
-131.91%-5.83M
53.08%-1.69M
27.68%-2.46M
88.39%-719.73K
69.22%-2.51M
38.86%-3.59M
45.00%-3.4M
-481.58%-6.2M
-1,874.24%-8.17M
Asset Impairment Loss
880.67%628.57K
-201.27%-196.48K
842.73%660.31K
-526.62%-329.66M
-93.10%64.1K
-70.51%194.02K
-56.44%70.04K
34.82%-52.61M
7,849.82%929.05K
-6.13%657.84K
Other net revenue
-34.76%88.64M
-24.21%60.9M
-19.30%27.56M
-5,128.21%-209.17M
94.06%135.85M
149.84%80.34M
379.34%34.16M
89.23%-4M
646.34%70.01M
208.99%32.16M
Fair value change income
-19.67%60.82M
-33.99%39.09M
-46.73%18.52M
1,579.99%85.74M
251.95%75.71M
578.63%59.22M
518.81%34.76M
-52.37%5.1M
--21.51M
---12.37M
Invest income
-81.17%7.81M
-3.52%6.71M
0.22%1.19M
-63.82%14.01M
-13.88%41.49M
-85.56%6.95M
--1.19M
19.55%38.73M
587.91%48.18M
563.52%48.18M
Asset deal income
-163.20%-302.55K
-163.86%-125.11K
----
1,798.54%1.3M
748.63%478.75K
101.55%195.92K
-59.27%33.35K
107.87%68.47K
107.23%56.41K
112.64%97.2K
Other revenue
19.96%22.59M
30.41%21.25M
423.10%8.88M
170.27%21.89M
240.53%18.83M
332.69%16.3M
-0.31%1.7M
8.19%8.1M
30.59%5.53M
36.75%3.77M
Operating profit
-16.78%480.3M
-7.39%366.57M
-14.93%174.75M
-33.25%355.23M
14.24%577.18M
17.04%395.82M
64.46%205.42M
20.12%532.18M
28.69%505.26M
38.93%338.19M
Add:Non operating Income
155.77%5.99M
586.88%5.16M
121.58%1.59M
-31.65%3.8M
-25.68%2.34M
-70.50%750.84K
-26.75%719.4K
74.65%5.56M
9.33%3.15M
3.22%2.55M
Less:Non operating expense
35.77%5.87M
30.37%3.88M
-79.80%68.87K
-7.40%5.31M
-1.27%4.32M
64.95%2.98M
164.55%340.88K
83.83%5.74M
435.10%4.38M
328.20%1.8M
Total profit
-16.48%480.43M
-6.54%367.85M
-14.35%176.27M
-33.51%353.71M
14.12%575.2M
16.13%393.59M
63.64%205.8M
20.06%532M
27.70%504.03M
38.07%338.93M
Less:Income tax cost
-32.76%67.99M
-14.46%52.15M
-22.01%24.51M
22.02%105.56M
34.59%101.11M
16.30%60.96M
66.20%31.43M
1.97%86.51M
21.41%75.13M
26.69%52.42M
Net profit
-13.01%412.43M
-5.09%315.7M
-12.97%151.76M
-44.30%248.15M
10.54%474.09M
16.10%332.63M
63.19%174.37M
24.34%445.49M
28.87%428.9M
40.38%286.51M
Net profit from continuing operation
-13.01%412.43M
-5.09%315.7M
-12.97%151.76M
-42.86%215.14M
10.54%474.09M
16.10%332.63M
63.19%174.37M
5.09%376.5M
28.87%428.9M
40.38%286.51M
Net income from discontinuing operating
----
----
----
-52.15%33.01M
----
----
----
--68.99M
----
----
Less:Minority Profit
-102.71%-271.35K
-103.99%-267.35K
-106.51%-264.04K
-19.62%10.68M
-5.63%10.02M
-12.53%6.71M
22.97%4.06M
-3.34%13.29M
13.65%10.62M
20.19%7.67M
Net profit of parent company owners
-11.07%412.7M
-3.05%315.97M
-10.74%152.02M
-45.06%237.47M
10.95%464.07M
16.88%325.92M
64.47%170.32M
25.45%432.2M
29.31%418.28M
41.03%278.84M
Earning per share
Basic earning per share
-10.87%0.82
-3.08%0.63
-11.76%0.3
-45.35%0.47
10.84%0.92
18.18%0.65
61.90%0.34
8.86%0.86
9.21%0.83
19.57%0.55
Diluted earning per share
-10.87%0.82
-3.08%0.63
-11.76%0.3
-45.35%0.47
10.84%0.92
18.18%0.65
61.90%0.34
8.86%0.86
9.21%0.83
19.57%0.55
Other composite income
Total composite income
-13.01%412.43M
-5.09%315.7M
-12.97%151.76M
-44.30%248.15M
10.54%474.09M
16.10%332.63M
63.19%174.37M
19.41%445.49M
22.58%428.9M
20.98%286.51M
Total composite income of parent company owners
-11.07%412.7M
-3.05%315.97M
-10.74%152.02M
-45.06%237.47M
10.95%464.07M
16.88%325.92M
64.47%170.32M
20.28%432.2M
22.82%418.28M
21.00%278.84M
Total composite income of minority owners
-102.71%-271.35K
-103.99%-267.35K
-106.51%-264.04K
-19.62%10.68M
-5.63%10.02M
-12.53%6.71M
22.97%4.06M
-3.34%13.29M
13.65%10.62M
20.19%7.67M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -43.16%1.25B-41.87%895.74M-44.36%448.45M-3.87%2.65B5.17%2.19B10.16%1.54B23.11%805.93M4.08%2.76B3.54%2.08B8.02%1.4B
Operating revenue -43.16%1.25B-41.87%895.74M-44.36%448.45M-3.87%2.65B5.17%2.19B10.16%1.54B23.11%805.93M4.08%2.76B3.54%2.08B8.02%1.4B
Other operating revenue -----7.47%576.89K----138.05%845.92K----120.05%623.44K-----142.70%-2.22M-----151.32%-3.11M
Total operating cost -51.21%853.44M-51.85%590.06M-52.53%301.27M-6.07%2.09B6.17%1.75B12.15%1.23B22.64%634.66M2.41%2.22B1.18%1.65B2.91%1.09B
Operating cost -62.07%415.05M-61.74%295.36M-65.93%144.46M0.16%1.25B16.92%1.09B21.69%772.07M42.64%424.06M9.71%1.25B7.84%935.94M12.04%634.46M
Operating tax surcharges -17.43%12.96M-25.25%8.02M-29.07%4.02M-8.43%20.07M-6.11%15.7M3.03%10.73M16.30%5.66M9.67%21.92M22.02%16.72M16.50%10.41M
Operating expense -39.71%273.79M-39.81%192.73M-34.36%104.04M-16.23%582.59M-12.33%454.12M-5.47%320.21M-4.73%158.5M-9.43%695.45M-6.81%517.97M-6.20%338.73M
Administration expense -20.14%127.76M-20.14%80.67M-15.06%37.96M-15.27%194.85M0.26%159.98M2.39%101.01M-7.47%44.69M12.96%229.97M13.05%159.57M19.06%98.66M
Financial expense -1.65%-23.49M-4.35%-17.04M0.34%-8.21M-20.63%-30.49M-26.14%-23.11M-32.30%-16.33M-32.77%-8.23M-22.68%-25.28M-606.60%-18.32M-600.57%-12.35M
-Interest expense (Financial expense) -69.64%125.07K-62.90%104.47K-83.78%18.61K-26.86%455.59K-19.97%412K-20.23%281.61K-35.65%114.73K-94.08%622.91K-93.21%514.8K-92.43%353.01K
-Interest Income (Financial expense) -0.26%-23.87M-3.36%-17.32M1.78%-8.27M-19.44%-31.29M-24.77%-23.81M-30.01%-16.75M-30.42%-8.42M16.83%-26.2M-82.00%-19.08M-94.32%-12.89M
Research and development -1.38%47.38M-19.58%30.32M90.36%19.01M36.54%67.7M34.85%48.04M65.56%37.71M45.32%9.98M-16.38%49.58M-31.85%35.63M-48.68%22.77M
Credit Impairment Loss -303.88%-2.91M-131.91%-5.83M53.08%-1.69M27.68%-2.46M88.39%-719.73K69.22%-2.51M38.86%-3.59M45.00%-3.4M-481.58%-6.2M-1,874.24%-8.17M
Asset Impairment Loss 880.67%628.57K-201.27%-196.48K842.73%660.31K-526.62%-329.66M-93.10%64.1K-70.51%194.02K-56.44%70.04K34.82%-52.61M7,849.82%929.05K-6.13%657.84K
Other net revenue -34.76%88.64M-24.21%60.9M-19.30%27.56M-5,128.21%-209.17M94.06%135.85M149.84%80.34M379.34%34.16M89.23%-4M646.34%70.01M208.99%32.16M
Fair value change income -19.67%60.82M-33.99%39.09M-46.73%18.52M1,579.99%85.74M251.95%75.71M578.63%59.22M518.81%34.76M-52.37%5.1M--21.51M---12.37M
Invest income -81.17%7.81M-3.52%6.71M0.22%1.19M-63.82%14.01M-13.88%41.49M-85.56%6.95M--1.19M19.55%38.73M587.91%48.18M563.52%48.18M
Asset deal income -163.20%-302.55K-163.86%-125.11K----1,798.54%1.3M748.63%478.75K101.55%195.92K-59.27%33.35K107.87%68.47K107.23%56.41K112.64%97.2K
Other revenue 19.96%22.59M30.41%21.25M423.10%8.88M170.27%21.89M240.53%18.83M332.69%16.3M-0.31%1.7M8.19%8.1M30.59%5.53M36.75%3.77M
Operating profit -16.78%480.3M-7.39%366.57M-14.93%174.75M-33.25%355.23M14.24%577.18M17.04%395.82M64.46%205.42M20.12%532.18M28.69%505.26M38.93%338.19M
Add:Non operating Income 155.77%5.99M586.88%5.16M121.58%1.59M-31.65%3.8M-25.68%2.34M-70.50%750.84K-26.75%719.4K74.65%5.56M9.33%3.15M3.22%2.55M
Less:Non operating expense 35.77%5.87M30.37%3.88M-79.80%68.87K-7.40%5.31M-1.27%4.32M64.95%2.98M164.55%340.88K83.83%5.74M435.10%4.38M328.20%1.8M
Total profit -16.48%480.43M-6.54%367.85M-14.35%176.27M-33.51%353.71M14.12%575.2M16.13%393.59M63.64%205.8M20.06%532M27.70%504.03M38.07%338.93M
Less:Income tax cost -32.76%67.99M-14.46%52.15M-22.01%24.51M22.02%105.56M34.59%101.11M16.30%60.96M66.20%31.43M1.97%86.51M21.41%75.13M26.69%52.42M
Net profit -13.01%412.43M-5.09%315.7M-12.97%151.76M-44.30%248.15M10.54%474.09M16.10%332.63M63.19%174.37M24.34%445.49M28.87%428.9M40.38%286.51M
Net profit from continuing operation -13.01%412.43M-5.09%315.7M-12.97%151.76M-42.86%215.14M10.54%474.09M16.10%332.63M63.19%174.37M5.09%376.5M28.87%428.9M40.38%286.51M
Net income from discontinuing operating -------------52.15%33.01M--------------68.99M--------
Less:Minority Profit -102.71%-271.35K-103.99%-267.35K-106.51%-264.04K-19.62%10.68M-5.63%10.02M-12.53%6.71M22.97%4.06M-3.34%13.29M13.65%10.62M20.19%7.67M
Net profit of parent company owners -11.07%412.7M-3.05%315.97M-10.74%152.02M-45.06%237.47M10.95%464.07M16.88%325.92M64.47%170.32M25.45%432.2M29.31%418.28M41.03%278.84M
Earning per share
Basic earning per share -10.87%0.82-3.08%0.63-11.76%0.3-45.35%0.4710.84%0.9218.18%0.6561.90%0.348.86%0.869.21%0.8319.57%0.55
Diluted earning per share -10.87%0.82-3.08%0.63-11.76%0.3-45.35%0.4710.84%0.9218.18%0.6561.90%0.348.86%0.869.21%0.8319.57%0.55
Other composite income
Total composite income -13.01%412.43M-5.09%315.7M-12.97%151.76M-44.30%248.15M10.54%474.09M16.10%332.63M63.19%174.37M19.41%445.49M22.58%428.9M20.98%286.51M
Total composite income of parent company owners -11.07%412.7M-3.05%315.97M-10.74%152.02M-45.06%237.47M10.95%464.07M16.88%325.92M64.47%170.32M20.28%432.2M22.82%418.28M21.00%278.84M
Total composite income of minority owners -102.71%-271.35K-103.99%-267.35K-106.51%-264.04K-19.62%10.68M-5.63%10.02M-12.53%6.71M22.97%4.06M-3.34%13.29M13.65%10.62M20.19%7.67M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data